CV Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY - Narrative (Details)

STOCKHOLDERS' EQUITY - Narrative (Details) $ / shares in Units, $ in Thousands		1 Months Ended	3 Months Ended				9 Months Ended
	Mar. 30, 2022 USD ($) vote $ / shares shares	Apr. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) yr $ / shares shares	Jun. 30, 2023 USD ($) shares	Sep. 30, 2022 USD ($)	Mar. 31, 2022 USD ($) shares	Sep. 30, 2023 USD ($) yr $ / shares shares	Sep. 30, 2022 USD ($) shares	Dec. 31, 2022 $ / shares shares	Jun. 06, 2022 shares	Jun. 05, 2022 shares	Mar. 29, 2022 shares
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock for services				$ 100		$ 384
Capital stock authorized (in shares) \| shares										800,000,000	200,000,000
Common stock authorized (in shares) \| shares	790,000,000		790,000,000				790,000,000		790,000,000	790,000,000	190,000,000	190,000,000
Securities called by preferred stock and warrants (in shares) \| shares	10,000,000
Preferred stock par value (in USD per share) \| $ / shares	$ 0.0001		$ 0.0001				$ 0.0001		$ 0.0001
Proceeds from issuance of preferred stock	$ 700
Payments of stock issuance costs	600
Deduction from proceeds, related to agent’s fees and other offering expenses	$ 100
Preferred stock, stated value, subjected to conversion (in USD per share) \| $ / shares	$ 1,000
Preferred stock, convertible into common stock (in shares) \| shares	10,000,000
Preferred stock conversion price (in USD per share) \| $ / shares	$ 0.07
Number of shares underlying warrants (in shares) \| shares			10,750,000				10,750,000		10,750,000
Fair value recorded as additional offering cost	$ 100
Number of votes per share of common stock underlying the preferred stock \| vote	170,000
Preferred stock authorized (in shares) \| shares	800,000,000		10,000,000				10,000,000		10,000,000			200,000,000
Deemed dividend for beneficial conversion of Series A convertible preferred stock		$ 900	$ 0		$ 0		$ 0	$ 920
Maximum
Subsidiary, Sale of Stock [Line Items]
Stock split, conversion ratio	0.1
Minimum
Subsidiary, Sale of Stock [Line Items]
Stock split, conversion ratio	0.0025
Warrants with $0.1000 Exercise Price
Subsidiary, Sale of Stock [Line Items]
Exercise price (in USD per share) \| $ / shares	$ 0.10		$ 0.1000				$ 0.1000
Number of shares underlying warrants (in shares) \| shares			10,000,000				10,000,000		10,000,000
Warrants with $0.0875 Exercise Price
Subsidiary, Sale of Stock [Line Items]
Exercise price (in USD per share) \| $ / shares	$ 0.0875		$ 0.0875				$ 0.0875
Number of shares underlying warrants (in shares) \| shares	750,000		750,000				750,000		750,000
Contractual term
Subsidiary, Sale of Stock [Line Items]
Fair value of the warrants issued, assumptions \| yr			3				3
Expected volatility rate
Subsidiary, Sale of Stock [Line Items]
Fair value of the warrants issued, assumptions			1.040				1.040
Risk-free interest rate
Subsidiary, Sale of Stock [Line Items]
Fair value of the warrants issued, assumptions			0.025				0.025
Expected dividend rate
Subsidiary, Sale of Stock [Line Items]
Fair value of the warrants issued, assumptions			0				0
Series A Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Stock issued during period (in shares) \| shares	700
Common Stock
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock for services (in shares) \| shares				2,500,000		3,496,000	2,500,000	3,496,000
Issuance of common stock for services								$ 400
Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of preferred stock							$ 400
Payments of stock issuance costs							100
Preferred stock, net of stock issuance costs							300
Warrants
Subsidiary, Sale of Stock [Line Items]
Payments of stock issuance costs							100
Proceeds from warrants issued							300
Warrants, net of stock issuance costs							$ 200